Role of the microcirculation in diabetic foot ulceration

International Journal of Lower Extremity Wounds

Volumn 5, Issue 3, 2006, Pages 144-148

  Korzon Burakowska, Anna ^a   Edmonds, Michael ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetic foot ulceration; Microcirculation; Pathogenesis

Indexed keywords

HEMOGLOBIN; OXYGEN;

BASEMENT MEMBRANE; BLOOD FLOW; BLOOD RHEOLOGY; CAPILLARY; CAPILLARY FLOW; DIABETIC FOOT; HEALING IMPAIRMENT; HUMAN; MICROCIRCULATION; MICROVASCULARIZATION; OXYGEN SATURATION; PRIORITY JOURNAL; REVIEW; RISK; TISSUE INJURY; ULCER; VASOCONSTRICTION;

BLOOD FLOW VELOCITY; DIABETIC FOOT; FOOT; HUMANS; MICROCIRCULATION; SKIN; VASODILATION;

EID: 33747076344     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734606292037     Document Type: Review

References (41)

1. Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: a role for microcirculation? Diabet Med 1992;9:320-9.
2. Krishnan TM, Rayman G. Microcirculation and diabetic foot. In: Boulton AJM, Cavanagh PR, Rayman G, editors. The foot in diabetes. Chichester, UK: Wiley; 2006. p. 41-50.
3. Goldenberg S, Alex M, Joshi RA, Blumenthal HT. Non atheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes 1959;8:261-73.
4. Logerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes; implications for foot care. N Engl J Med 1984;311:1615-19.
5. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-9.
6. Dinh T, Veves A. Microcirculation of the diabetic foot. Curr Pharm Des 2005;11:2301-9.
7. Watkins PJ, Edmonds ME. Diabetic autonomic failure. In: Mathias CJ, Bannister R, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford (UK): Oxford University Press; 1999. p. 378-86.
8. Archer AG, Roberts VC, Watkins PJ. Blood flow patterns in painful diabetic neuropathy. Diabetologia 1984;27:563-7.
9. Jörneskog G, Brismar K, Fagrell B. Skin capillary circulation is severely impaired in toes of patients with IDDM with and without late diabetic complications. Diabetologia 1995;38:474-80.
10. Jörneskog G, Fagrell B. Discrepancy in skin capillary circulation between fingers and toes in patients with type 1 diabetes. Int J Microcirc Clin Exp 1996;16:313-19.
11. Jörneskog G, Brismar K, Fagrell B. Pronounced skin capillary ischemia in the feet of diabetic patients with bad metabolic control. Diabetologia 1998;41:410-15.
12. Flynn MD, Edmonds ME, Tooke JE, Watkins PJ. Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia 1988;31:652-66.
13. Fagrell B, Jorneskog G, Intaglietta M. Disturbed microvascular reactivity and shunting - a major cause for diabetic complications. Vasc Med 1999;4:125-7.
14. Netten PM, Wollersheim H, Thien T, Lutterman JA. Skin microcirculation of the foot in diabetic neuropathy. Clin Sci 1996;91:559-65.
15. Sandemann DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992;327:760-4.
16. Rayman G, Malik RA, Sharma AK, Day JL. Microvascular response to tissue injury and capillary ultrastructure in the foot skin type 1 diabetic patients. Clin Sci 1995;89:467-74.
17. Jaap AJ, Tooke JE. Is microvascular disease important in the diabetic foot? In: Boulton JM, Connor H, Cavanagh PR, editors. The foot in diabetes. Chichester (UK): Wiley; 1994. p. 49-56.
18. Sandeman DD, Pym CA, Green EM, Seamark C, Shore AC, Tooke JE. Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients. BMJ 1991;302:1122-3.
19. Railton R, Newman P, Hislop J, Harrower AD. Reduced transcutaneous oxygen tension and impaired vascular response in type 1 (insulin dependent) diabetes. Diabetologia 1983;25:340-2.
20. Uccioli L, Monticone G, Russo F, Mormile F, Durola L, Mennuni G, et al. Autonomic neuropathy and transcutaneous oxymetry in diabetic lower extremities. Diabetologia 1994;37:1051-5.
21. Casselli A, Rich J, Hanane T, Uccioli L, Veves A. Role of c-nociceptive fibers in the nerve axon reflex-related vasodilatation in diabetes. Neurology 2003;60:297-300.
22. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988;318:1306-9.
23. Walmsley D, Wiles PG. Early loss of neurogenic inflammation in the human diabetic foot. Clin Sci 1991;80:605-10.
24. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin dependent diabetes. J Clin Invest 1992;90:2548-54.
25. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium dependent and independent vasodilation in patients with type 2 (non insulin dependent) diabetes mellitus. Diabetologia 1992;35:771-6.
26. Krishnan ST, Rayman G. The LDI flare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004;27:2930-5.
27. Greenman RL, Panasyuk S, Wang X, Lyons TE, Dinh T, Longoria L, et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 2005;336:1711-17.
28. McMillan DE, Utterback NG, Stocki J. Low shear rate blood viscosity in diabetes. Biorheology 1980;17:355-62.
29. Ernst E, Matrai A. Altered red and white blood cell rheology in type 2 diabetes. Diabetes 1986;35;1412-15.
30. MacRury SM, Lowe GD. Blood rheology in diabetes mellitus. Diabet Med 1990;7:285-91.
31. Lowe GD, Ghafour IM, Belch JJ, Forbes CD, Foulds WS, MacCuish AC. Increased blood viscosity in diabetic proliferative retinopathy. Diabetes Res 1984;1:67-70.
32. Pitei DL, Watkins PJ, Edmonds ME. NO-dependent smooth muscle vasodilatation is reduced in the NIDDM patients with peripheral sensory neuropathy. Diabet Med 1997;14:284-90.
33. Krishnan ST, Baker NR, Carrington AL, Rayman G. Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes. Diabetes Care 2004;27:1343-8.
34. Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care 1998;21:1339-44.
35. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856-62.
36. Rayman G, Baker NR, Krishnan STM. Wound healing and microvascular responses in the foot skin of type 2 diabetic subjects with neuropathy [abstract]. Diabetic Foot Study Group, 5th Meeting, 2005, Greece.
37. Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet 1983;1:548-51.
38. Edmonds M, Foster AVM, Sanders LJ. A practical manual of diabetic foot care. Oxford (UK): Blackwell Science; 2004.
39. Quigley FG, Faris IB, Duncan HJ. A comparison of Doppler ankle pressures and skin perfusion pressure in subjects with and without diabetes. Clin Physiol 1991;11:21-5.
40. Arora S, Pomposelli F, Lo Gerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002;35:501-5.
41. Zimmermann J, Schramm L, Wanner C, Mulzer E, Henrich HA, Langer R, et al. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy. Clin Nephrol 1996;46:230-6.